Time Toxicity in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine Plus Cisplatin With or Without DurvalumabN. Okano, Mitesh J. Borad, C. O'Donnell et al.|JCO oncology advances.|2026Cited by 0